Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization

Michael J Ciancanelli1, Christopher F Basler

  • 1Department of Microbiology, Box 1124, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029, USA.

Journal of Virology
|September 29, 2006
PubMed

Insights

Nipah virus matrix (M) protein budding was studied. A YMYL sequence was found to be crucial for virus-like particle release, acting as a late domain.

Area of Science:

  • Virology
  • Molecular Biology
  • Cell Biology

Background:

  • Matrix (M) proteins are essential for paramyxovirus budding.
  • Nipah virus (NiV) is an emerging, highly lethal paramyxovirus requiring assembly process characterization.

Purpose of the Study:

  • To investigate the assembly and budding mechanism of the Nipah virus matrix (M) protein.
  • To identify functional domains within the NiV M protein involved in viral egress.

Main Methods:

  • Expression of NiV M protein to form virus-like particles (VLPs).
  • Site-directed mutagenesis of a putative late domain (YMYL) in NiV M.
  • Complementation assays using Ebola virus VP40 matrix protein.

Main Results:

  • NiV M expression alone produced VLPs resembling NiV.
  • Mutation of the YMYL sequence abolished VLP release and caused M protein nuclear relocalization.
  • The YMYL sequence restored budding when fused to a mutant Ebola virus VP40 protein.

Conclusions:

  • The YMYL sequence in NiV M functions as a critical late domain for viral budding.
  • This sequence likely acts as a trafficking signal directing M protein to the plasma membrane for egress.
  • Understanding NiV M's role in budding is crucial for developing antiviral strategies.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...